CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- 4 Open-market buy 10% owner bought 3,000,000 shares at $1.00 ($3,000,000)
- 4 Open-market buy Director bought 8,360,000 shares at $1.00 ($8,360,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $0.72 ($7,245)
- 4/A Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $0.67 ($6,731)
- 4 Open-market buy Director bought 10,000 shares at $0.62 ($6,200)
- 4 Open-market buy 10% owner bought 823,045 shares at $1.22 ($1,000,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 16 · 305 filings